FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313458145> ?p ?o ?g. }

• W4313458145 abstract "Abstract Purpose A series of iterative population pharmacokinetic (PK) modelling and probability of target attainment (PTA) analyses were undertaken to support dose optimization for aztreonam-avibactam, a combination antibiotic. Methods Joint PTA analyses (primary target: 60% f T>8 mg/L for aztreonam, 50% f T>2.5 mg/L for avibactam) explored the impact of patient variability, and evaluated loading doses and extended infusions, and adjustments for patients with moderate (estimated creatinine clearance [CrCL] >30 to ≤50 mL/min) and severe renal impairment (>15 to ≤30 mL/min). Achievement of >90% joint PTA, and the impact of differential renal clearance, were considerations in dose selection. Results Dose selection for phase I and phase IIa (Cohort 1) was based on PK models of avibactam in patients and of aztreonam in healthy volunteers with ‘patient-like’ assumptions. Simulations demonstrated that: 3-h and continuous infusions provide comparable PTA; with patient variability, avibactam dose is the main driver of joint PTA; loading doses support more rapid joint target attainment. Aztreonam/avibactam 500/137 mg 30-min loading dose and 1500/410 mg 3-h maintenance infusions q6h was selected for initial phase IIa evaluation in patients with complicated intra-abdominal infection. Later PTA analyses using expanded PK models supported an increased avibactam dose (500/167 mg loading; 1500/500 q6h maintenance) and were also used to select doses for renal impairment. Conclusion Aztreonam-avibactam 3-h infusions administered q6h are necessary to optimize joint PTA. Aztreonam-avibactam 500/167 mg loading 30-min infusion followed by 1500/500 mg maintenance 3-h infusions q6h (for CrCL >50 mL/min) is undergoing phase III evaluation. Clinical trial registration: NCT01689207 (September 21, 2012); NCT02655419 (January 14, 2016); NCT03329092 (November 1, 2017); NCT03580044 (July 9, 2018)" @default.
• W4313458145 created "2023-01-06" @default.
• W4313458145 creator A5003940986 @default.
• W4313458145 creator A5029829921 @default.
• W4313458145 creator A5035996923 @default.
• W4313458145 creator A5059929229 @default.
• W4313458145 creator A5065766712 @default.
• W4313458145 creator A5070064777 @default.
• W4313458145 creator A5080674509 @default.
• W4313458145 creator A5080960238 @default.
• W4313458145 creator A5081984076 @default.
• W4313458145 creator A5082287424 @default.
• W4313458145 date "2023-01-03" @default.
• W4313458145 modified "2023-09-27" @default.
• W4313458145 title "Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for phase IIa and phase III evaluation" @default.
• W4313458145 cites W1859101832 @default.
• W4313458145 cites W1916323032 @default.
• W4313458145 cites W1974451627 @default.
• W4313458145 cites W1997697547 @default.
• W4313458145 cites W2000662787 @default.
• W4313458145 cites W2053859361 @default.
• W4313458145 cites W2061804662 @default.
• W4313458145 cites W2080319012 @default.
• W4313458145 cites W2123305940 @default.
• W4313458145 cites W2128484737 @default.
• W4313458145 cites W2140518380 @default.
• W4313458145 cites W2161554526 @default.
• W4313458145 cites W2409425533 @default.
• W4313458145 cites W2463855494 @default.
• W4313458145 cites W2513003413 @default.
• W4313458145 cites W2777624293 @default.
• W4313458145 cites W2796052358 @default.
• W4313458145 cites W2890151803 @default.
• W4313458145 cites W2891577800 @default.
• W4313458145 cites W2904562125 @default.
• W4313458145 cites W2909817794 @default.
• W4313458145 cites W2913385089 @default.
• W4313458145 cites W2985769491 @default.
• W4313458145 cites W2997554990 @default.
• W4313458145 cites W3005408381 @default.
• W4313458145 cites W3007020664 @default.
• W4313458145 cites W3192530548 @default.
• W4313458145 cites W3200554152 @default.
• W4313458145 cites W4200036649 @default.
• W4313458145 cites W4200250437 @default.
• W4313458145 cites W4206123145 @default.
• W4313458145 cites W4224266833 @default.
• W4313458145 cites W4226214387 @default.
• W4313458145 cites W4251121716 @default.
• W4313458145 cites W4283513605 @default.
• W4313458145 cites W4309245109 @default.
• W4313458145 doi "https://doi.org/10.21203/rs.3.rs-2406580/v1" @default.
• W4313458145 hasPublicationYear "2023" @default.
• W4313458145 type Work @default.
• W4313458145 citedByCount "0" @default.
• W4313458145 crossrefType "posted-content" @default.
• W4313458145 hasAuthorship W4313458145A5003940986 @default.
• W4313458145 hasAuthorship W4313458145A5029829921 @default.
• W4313458145 hasAuthorship W4313458145A5035996923 @default.
• W4313458145 hasAuthorship W4313458145A5059929229 @default.
• W4313458145 hasAuthorship W4313458145A5065766712 @default.
• W4313458145 hasAuthorship W4313458145A5070064777 @default.
• W4313458145 hasAuthorship W4313458145A5080674509 @default.
• W4313458145 hasAuthorship W4313458145A5080960238 @default.
• W4313458145 hasAuthorship W4313458145A5081984076 @default.
• W4313458145 hasAuthorship W4313458145A5082287424 @default.
• W4313458145 hasBestOaLocation W43134581451 @default.
• W4313458145 hasConcept C104317684 @default.
• W4313458145 hasConcept C111113717 @default.
• W4313458145 hasConcept C112705442 @default.
• W4313458145 hasConcept C126322002 @default.
• W4313458145 hasConcept C126894567 @default.
• W4313458145 hasConcept C185592680 @default.
• W4313458145 hasConcept C2777058267 @default.
• W4313458145 hasConcept C2777406300 @default.
• W4313458145 hasConcept C2779631663 @default.
• W4313458145 hasConcept C2780416669 @default.
• W4313458145 hasConcept C35294091 @default.
• W4313458145 hasConcept C501593827 @default.
• W4313458145 hasConcept C547475151 @default.
• W4313458145 hasConcept C55493867 @default.
• W4313458145 hasConcept C71924100 @default.
• W4313458145 hasConcept C72563966 @default.
• W4313458145 hasConcept C94665300 @default.
• W4313458145 hasConceptScore W4313458145C104317684 @default.
• W4313458145 hasConceptScore W4313458145C111113717 @default.
• W4313458145 hasConceptScore W4313458145C112705442 @default.
• W4313458145 hasConceptScore W4313458145C126322002 @default.
• W4313458145 hasConceptScore W4313458145C126894567 @default.
• W4313458145 hasConceptScore W4313458145C185592680 @default.
• W4313458145 hasConceptScore W4313458145C2777058267 @default.
• W4313458145 hasConceptScore W4313458145C2777406300 @default.
• W4313458145 hasConceptScore W4313458145C2779631663 @default.
• W4313458145 hasConceptScore W4313458145C2780416669 @default.
• W4313458145 hasConceptScore W4313458145C35294091 @default.
• W4313458145 hasConceptScore W4313458145C501593827 @default.
• W4313458145 hasConceptScore W4313458145C547475151 @default.
• W4313458145 hasConceptScore W4313458145C55493867 @default.
• W4313458145 hasConceptScore W4313458145C71924100 @default.
• W4313458145 hasConceptScore W4313458145C72563966 @default.

• next